2007
A Case of Metastatic Adenocarcinoma Presenting with Fulminant Hepatic Failure and Elevated Alpha Fetoprotein Level
Sivaprakasapillai N, Fayad N, Chaptini L, Deitch C, Depenbusch J. A Case of Metastatic Adenocarcinoma Presenting with Fulminant Hepatic Failure and Elevated Alpha Fetoprotein Level. The American Journal Of Gastroenterology 2007, 102: s375. DOI: 10.14309/00000434-200709002-00699.Peer-Reviewed Case Reports and Technical NotesElevated alpha-fetoprotein levelsAlpha-fetoprotein levelsFulminant hepatic failureHepatic failureMetastatic adenocarcinomaFetoprotein levelsAdenocarcinoma
1985
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival
Ihde D, Matthews M, Makuch R, McIntire K, Eddy J, Seeff L. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival. The American Journal Of Medicine 1985, 78: 399-406. PMID: 2579551, DOI: 10.1016/0002-9343(85)90330-4.Peer-Reviewed Original ResearchConceptsAlpha-fetoprotein levelsFibrolamellar carcinomaHepatocellular carcinomaSystemic chemotherapyNormal serum alpha-fetoprotein levelsHepatitis B serum markersNormal alpha-fetoprotein levelsSerum alpha-fetoprotein levelsElevated alpha-fetoprotein levelsAmbulatory performance statusHomogeneous clinical featuresAbsence of cirrhosisHepatitis B markersTime of diagnosisGroup of patientsInitiation of treatmentLack of jaundiceAmbulatory statusExtrahepatic metastasesPerformance statusImproved survivalIndolent coursePrognostic factorsClinical featuresSerum markers
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply